Rethinking risk factors this Liver Cancer Awareness Month
Learn how to engage with our campaign and help protect your liver health. Every year, Liver Cancer Awareness Month (LCAM) is an opportunity to bring the sixth most prevalent cancer globally to the forefront of conversation, promoting awareness and the importance of early diagnosis.1 Hepatocellular carcinoma (HCC), the most common type of primary liver cancer1, is projected to become the third leading cause of cancer-related death by 2030, making it an area of urgent and growing need.
This is why, in 2021, we are continuing our partnership with the European Liver Patients Association (ELPA), with the goal of encouraging everyone to ask themselves, “Am I at risk of liver cancer?” Building on the momentum from last year’s campaign, we are excited to announce that Liv the Liver and her family of organs are returning with a new episode, accompanied by activities to highlight the importance of acting upon risk factors and seeking medical advice.
We encourage everyone to Rethink Liver Cancer this month!
- Llovet, J.M. et al. Hepatocellular carcinoma. Nat Rev Dis Primers 7, 6 (2021). https://doi.org/10.1038/s41572-020-00240-3
- Wang W. and Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes & Diseases. 2020. https://doi.org/10.1016/j.gendis.2020.01.014